04.22.24 -- How Continuous Bioprocessing Is Shaping Modern Biopharma Manufacturing

Explore the details supporting LNP-mediated mRNA delivery, as well as the challenges facing mRNA based therapeutics in the future.

Adaptability is crucial for developers as they upscale the production of viral vectors. Explore the benefits of using suspension cell lines and why adherent cell culture shouldn’t be left behind.

The secure, leak-free connection of sensors to single-use assemblies is paramount in ensuring both the accuracy of the measurements taken and protection of the manufacture of expensive drug products.

Explore the integration of high cell density cryopreservation in the seed train and key considerations for developing a cryopreservation process.

Learn how a CDMO partner that addresses challenges in CHO cell line development and implements efficient and reliable solutions can enable the efficient production of biopharmaceuticals.

Achieve continuous, on-line monitoring with measurements as often as every two minutes, with no loss of bioreactor volume and no risk of contamination.

Explore a single-use bioreactor and bioprocess controller pairing that allows for a bioreactor-based SARS-CoV-2 S HexaPro spike protein production developed using a suspension cell culture platform.

Learn about the key stages of drug discovery and screening as well as how to overcome bottlenecks in screening mRNA-LNPs to rapidly develop genomic medicines.